Reuters logo
5 months ago
BRIEF-Shanghai Shyndec Pharmaceutical unit receives GMP certificate
March 31, 2017 / 11:12 AM / 5 months ago

BRIEF-Shanghai Shyndec Pharmaceutical unit receives GMP certificate

March 31(Reuters) - Shanghai Shyndec Pharmaceutical Co Ltd :

* Says its Datong-based wholly owned subsidiary received goods manufacture practice (GMP) certificate from Shanxi Food and Drug Administration

* Certificate issued to amoxicillin clavulanate potassium manufactured by the subsidiary and the valid period is until March 19, 2022

Source text in Chinese: goo.gl/nsGvFr

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below